The Medical Devices sector report, “Artificial Pancreas - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to -
Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Artificial Pancreas under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Pancreas under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
1.2 List of Figures
2 Introduction
2.1 Artificial Pancreas Overview
3 Products under Development
3.1 Artificial Pancreas - Pipeline Products by Stage of Development
3.2 Artificial Pancreas - Pipeline Products by Territory
3.3 Artificial Pancreas - Pipeline Products by Regulatory Path
3.4 Artificial Pancreas - Pipeline Products by Estimated Approval Date
3.5 Artificial Pancreas - Ongoing Clinical Trials
3.2 Artificial Pancreas - Pipeline Products by Territory
3.3 Artificial Pancreas - Pipeline Products by Regulatory Path
3.4 Artificial Pancreas - Pipeline Products by Estimated Approval Date
3.5 Artificial Pancreas - Ongoing Clinical Trials
4 Artificial Pancreas - Pipeline Products under Development by Companies
4.1 Artificial Pancreas Companies - Pipeline Products by Stage of Development
4.2 Artificial Pancreas - Pipeline Products by Stage of Development
4.2 Artificial Pancreas - Pipeline Products by Stage of Development
5 Artificial Pancreas Companies and Product Overview
5.1 Admetsys Corp Company Overview
5.1.1 Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Biosensors-Ohio LLC Company Overview
5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Beta Bionics Inc Company Overview
5.3.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Beta-O2 Technologies Ltd Company Overview
5.4.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Bigfoot Biomedical Inc Company Overview
5.5.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 BioTex Inc Company Overview
5.6.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cerco Medical LLC Company Overview
5.7.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Converge Biotech, Inc. Company Overview
5.8.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Covalor Medical, LLC Company Overview
5.9.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 De Montfort University Company Overview
5.10.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Debiotech SA Company Overview
5.11.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.12 Defymed SAS Company Overview
5.12.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
5.13 Diabeloop SA Company Overview
5.13.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
5.14 EOFlow Co Ltd Company Overview
5.14.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Giner Inc Company Overview
5.15.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview
5.16.1 Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.17 Healios Inc Company Overview
5.17.1 Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Humacyte Inc Company Overview
5.18.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Ideal Medical Technologies Inc Company Overview
5.19.1 Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Imperial College London Company Overview
5.20.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.21 Inreda Diabetic BV Company Overview
5.21.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
5.22 Insulet Corp Company Overview
5.22.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Joslin Diabetes Center Company Overview
5.23.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview
5.24 Kencak LLC Company Overview
5.24.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
5.25 McGill University Company Overview
5.25.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Medtronic Diabetes Company Overview
5.26.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
5.27 Medtronic Inc Company Overview
5.27.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Miromatrix Medical Inc Company Overview
5.28.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Pacific Diabetes Technologies, Inc. Company Overview
5.29.1 Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.30 Pancreum, LLC Company Overview
5.30.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 PharmaCyte Biotech Inc Company Overview
5.31.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Polytechnic University of Valencia Company Overview
5.32.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.33 Rensselaer Polytechnic Institute Company Overview
5.33.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
5.34 Senseonics Holdings Inc Company Overview
5.34.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Stanford University Company Overview
5.35.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.36 TecMed Inc Company Overview
5.36.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 The Alfred Mann Foundation Company Overview
5.37.1 The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview
5.38 TypeZero Technologies LLC Company Overview
5.38.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.39 U-Needle BV Company Overview
5.39.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
5.40 Universidad Autonoma de Madrid Company Overview
5.40.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of California San Francisco Company Overview
5.41.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.42 University of California Santa Barbara Company Overview
5.42.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of Cambridge Company Overview
5.43.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
5.44 University of Florida Company Overview
5.44.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.45 University of Minnesota Company Overview
5.45.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.46 University of Newcastle Company Overview
5.46.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
5.47 WaveForm Technologies Inc Company Overview
5.47.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.48 XERIS Pharmaceuticals Inc Company Overview
5.48.1 XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.49 Yale University Company Overview
5.49.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
5.1.1 Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Biosensors-Ohio LLC Company Overview
5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Beta Bionics Inc Company Overview
5.3.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Beta-O2 Technologies Ltd Company Overview
5.4.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Bigfoot Biomedical Inc Company Overview
5.5.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 BioTex Inc Company Overview
5.6.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cerco Medical LLC Company Overview
5.7.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Converge Biotech, Inc. Company Overview
5.8.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Covalor Medical, LLC Company Overview
5.9.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 De Montfort University Company Overview
5.10.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Debiotech SA Company Overview
5.11.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.12 Defymed SAS Company Overview
5.12.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
5.13 Diabeloop SA Company Overview
5.13.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
5.14 EOFlow Co Ltd Company Overview
5.14.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Giner Inc Company Overview
5.15.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview
5.16.1 Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.17 Healios Inc Company Overview
5.17.1 Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Humacyte Inc Company Overview
5.18.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Ideal Medical Technologies Inc Company Overview
5.19.1 Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Imperial College London Company Overview
5.20.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.21 Inreda Diabetic BV Company Overview
5.21.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
5.22 Insulet Corp Company Overview
5.22.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Joslin Diabetes Center Company Overview
5.23.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview
5.24 Kencak LLC Company Overview
5.24.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
5.25 McGill University Company Overview
5.25.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Medtronic Diabetes Company Overview
5.26.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
5.27 Medtronic Inc Company Overview
5.27.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Miromatrix Medical Inc Company Overview
5.28.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Pacific Diabetes Technologies, Inc. Company Overview
5.29.1 Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.30 Pancreum, LLC Company Overview
5.30.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 PharmaCyte Biotech Inc Company Overview
5.31.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Polytechnic University of Valencia Company Overview
5.32.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.33 Rensselaer Polytechnic Institute Company Overview
5.33.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
5.34 Senseonics Holdings Inc Company Overview
5.34.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Stanford University Company Overview
5.35.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.36 TecMed Inc Company Overview
5.36.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 The Alfred Mann Foundation Company Overview
5.37.1 The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview
5.38 TypeZero Technologies LLC Company Overview
5.38.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.39 U-Needle BV Company Overview
5.39.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
5.40 Universidad Autonoma de Madrid Company Overview
5.40.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of California San Francisco Company Overview
5.41.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.42 University of California Santa Barbara Company Overview
5.42.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of Cambridge Company Overview
5.43.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
5.44 University of Florida Company Overview
5.44.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.45 University of Minnesota Company Overview
5.45.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.46 University of Newcastle Company Overview
5.46.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
5.47 WaveForm Technologies Inc Company Overview
5.47.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.48 XERIS Pharmaceuticals Inc Company Overview
5.48.1 XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.49 Yale University Company Overview
5.49.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
6 Artificial Pancreas - Recent Developments
6.1 May 06, 2021: Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year
6.2 May 05, 2021: University of Cambridge appoints Dr Diarmuid O’Brien as new Chief Executive of Cambridge Enterprise
6.3 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021
6.4 Mar 02, 2021: Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on March 9, 2021
6.5 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.6 Nov 09, 2020: Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
6.7 Aug 06, 2020: Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020
6.2 May 05, 2021: University of Cambridge appoints Dr Diarmuid O’Brien as new Chief Executive of Cambridge Enterprise
6.3 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021
6.4 Mar 02, 2021: Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on March 9, 2021
6.5 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.6 Nov 09, 2020: Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
6.7 Aug 06, 2020: Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
- Artificial Pancreas - Pipeline Products by Stage of Development
- Artificial Pancreas - Pipeline Products by Territory
- Artificial Pancreas - Pipeline Products by Regulatory Path
- Artificial Pancreas - Pipeline Products by Estimated Approval Date
- Artificial Pancreas - Ongoing Clinical Trials
- Artificial Pancreas Companies - Pipeline Products by Stage of Development
- Artificial Pancreas - Pipeline Products by Stage of Development
- Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
- Smart Pancreas - Product Status
- Smart Pancreas - Product Description
- Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
- Artificial Pancreas - Product Status
- Artificial Pancreas - Product Description
- Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Bihormonal iLet Bionic Pancreas - Product Status
- Bihormonal iLet Bionic Pancreas - Product Description
- Gen 2 GlucoSTAT - Product Status
- Gen 2 GlucoSTAT - Product Description
- Gen 4 iLet System - Product Status
- Gen 4 iLet System - Product Description
- iLet Bionic Pancreas - Glucagon-only - Product Status
- iLet Bionic Pancreas - Glucagon-only - Product Description
- iLet Bionic Pancreas - Insulin-only - Product Status
- iLet Bionic Pancreas - Insulin-only - Product Description
- Beta Bionics Inc - Ongoing Clinical Trials Overview
- Bihormonal iLet Bionic Pancreas - Feasibility of Outpatient Automated Blood Glucose Control with the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
- iLet Bionic Pancreas - Insulin-only - Feasibility of Outpatient Automated Blood Glucose Control with the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
- iLet Bionic Pancreas - Insulin-only - Individualizing Automated Closed Loop Glucose Control through Pharmacokinetic Profiling in an Insulin-only Bionic Pancreas
- iLet Bionic Pancreas - Insulin-only - The Insulin-only Bionic Pancreas Pivotal Trial: Testing the iLet in Adults and Children with Type 1 Diabetes
- Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
ßAir Bio-artificial Pancreas - Product Description
- Beta-O2 Technologies Ltd - Ongoing Clinical Trials Overview
- Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Bigfoot Smartloop System - Product Status
- Bigfoot Smartloop System - Product Description
- BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
- Artificial Pancreas - Product Status
- Artificial Pancreas - Product Description
- Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
- Bioartificial Pancreas - Product Status
- Bioartificial Pancreas - Product Description
- Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Bioartificial Pancreas System - Product Status
- Bioartificial Pancreas System - Product Description
- Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
- Artificial Pancreas - Product Status
- Artificial Pancreas - Product Description
- De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
- InSmart Artificial Pancreas - Product Status
- InSmart Artificial Pancreas - Product Description
- Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
- Next Generation Artificial Pancreas - Product Status
- Next Generation Artificial Pancreas - Product Description
- Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
- MAILPAN - Product Status
- MAILPAN - Product Description
- Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
- DBL-hu - Product Status
- DBL-hu - Product Description
- DBLG1 - Adults - Product Status
- DBLG1 - Adults - Product Description
- DBLG1 - Pediatric Version - Product Status
- DBLG1 - Pediatric Version - Product Description
- Diabeloop SA - Ongoing Clinical Trials Overview
- DBLG1 - Adults - Observational Study of the Use of DBLG1 System in Real Life
- EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- EOPancreas - Product Status
- EOPancreas - Product Description
- EOPatchX - Product Status
- EOPatchX - Product Description
- Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
- BAPIOS System - Product Status
- BAPIOS System - Product Description
- Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
- Pregnancy-Specific Artificial Pancreas - Product Status
- Pregnancy-Specific Artificial Pancreas - Product Description
- Harvard John A Paulson School of Engineering and Applied Sciences - Ongoing Clinical Trials Overview
- Pregnancy-Specific Artificial Pancreas - Observational Study of Patient Important Outcomes in Pregnant Patients with Type 1 Diabetes Mellitus on Insulin Pump
- Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
- Bioengineered Pancreas - Product Status
- Bioengineered Pancreas - Product Description
- Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
- BioVascular Pancreas - Product Status
- BioVascular Pancreas - Product Description
- Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- FUSION System - Product Status
- FUSION System - Product Description
- Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
- Bio-inspired Artificial Pancreas - Product Status
- Bio-inspired Artificial Pancreas - Product Description
- Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
- Bi-Hormonal Artificial Pancreas - Lighter Version - Product Status
- Bi-Hormonal Artificial Pancreas - Lighter Version - Product Description
- Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
- Omnipod 5 - Product Status
- Omnipod 5 - Product Description
- Insulet Corp - Ongoing Clinical Trials Overview
- Omnipod 5 - Automated Insulin Delivery for Inpatients with DysGlycemia (AIDING) Feasibility Study
- Omnipod 5 - Evaluating the Safety and Effectiveness of the Omnipod 5 Automated Insulin Delivery System in Patients with Type 2 Diabetes
- Omnipod 5 - Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Children with Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort
- Omnipod 5 - Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Patients with Type 1 Diabetes
- Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview
- Closed-Loop Glucagon Delivery System - Product Status
- Closed-Loop Glucagon Delivery System - Product Description
- Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
- BioArtificial Pancreas - Product Status
- BioArtificial Pancreas - Product Description
- McGill University Pipeline Products & Ongoing Clinical Trials Overview
- Artificial Pancreas - Type 1 Diabetes - Product Status
- Artificial Pancreas - Type 1 Diabetes - Product Description
- Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
- Minimed 780G - Adults - Product Status
- Minimed 780G - Adults - Product Description
- Minimed 890G - Product Status
- Minimed 890G - Product Description
- Medtronic Diabetes - Ongoing Clinical Trials Overview
- Minimed 780G - Adults - Advanced Hybrid Closed-Loop Treatment in Adults with Type 1 Diabetes Not Meeting Glycaemic Targets: A Randomized Controlled Trial - The Steno 780G Study
- Minimed 780G - Adults - An 8-day Initiation Protocol of Advanced Hybrid Closed Loop System in Children and Adolescents with Diabetes Type 1 on Multiple Daily Insulin Injection
- Minimed 780G - Adults - Closed-loop Insulin Delivery in Pregnant Women with Type 1 Diabetes: A Randomized Controlled Trial: The CRISTAL Study
- Minimed 780G - Adults - Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
- Minimed 780G - Adults - The MiniMed 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects with Type 1 Diabetes in France: EQOL Study
- Minimed 780G - Adults - Transition of Patients with T1D From Multiple Daily Injection (MDI) and Self-monitoring of Blood Glucose (SMBG) Directly to MiniMed 780G Advanced Hybrid Closed Loop (AHCL) System :Impact on Glucose Control and Quality of Life Measures
- Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
- Third-Generation Artificial Pancreas System - Product Status
- Third-Generation Artificial Pancreas System - Product Description
- Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Miro Pancreas - Product Status
- Miro Pancreas - Product Description
- Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- SynerG - Product Status
- SynerG - Product Description
- Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
- Genesis Artificial Pancreas - Product Status
- Genesis Artificial Pancreas - Product Description
- PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
- Bio-Artificial Pancreas - Product Status
- Bio-Artificial Pancreas - Product Description
- Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
- ClosedLoop 4Meal - Product Status
- ClosedLoop 4Meal - Product Description
- Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
- Closed-Loop Artificial Pancreas System - Product Status
- Closed-Loop Artificial Pancreas System - Product Description
- Rensselaer Polytechnic Institute - Ongoing Clinical Trials Overview
- Closed-Loop Artificial Pancreas System - Restoring Brain Metabolism and Function in Older Adult T1DM Patients Using an AP System
- Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
- Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Status
- Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Description
- Stanford University Pipeline Products & Ongoing Clinical Trials Overview
- Artificial Pancreas Device - Product Status
- Artificial Pancreas Device - Product Description
- TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- Artificial Pancreas - Product Status
- Artificial Pancreas - Product Description
- The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview
- Implantable Artificial Pancreas Device - Product Status
- Implantable Artificial Pancreas Device - Product Description
- TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
- inControl - Product Status
- inControl - Product Description
- U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
- Microneedle Artificial Pancreas - Product Status
- Microneedle Artificial Pancreas - Product Description
- Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
- Predictive Rule-Based Algorithm - Product Status
- Predictive Rule-Based Algorithm - Product Description
- University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
- Implantable Bioartificial Pancreas - Product Status
- Implantable Bioartificial Pancreas - Product Description
- University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
- Closed-Loop Artificial Pancreas - Product Status
- Closed-Loop Artificial Pancreas - Product Description
- Pediatric Artificial Pancreas - Product Status
- Pediatric Artificial Pancreas - Product Description
- University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
- Florence D2A System - Product Status
- Florence D2A System - Product Description
- FlorenceM - Product Status
- FlorenceM - Product Description
- University of Florida Pipeline Products & Ongoing Clinical Trials Overview
- Bioartificial Pancreas - Type 1 Diabetes - Product Status
- Bioartificial Pancreas - Type 1 Diabetes - Product Description
- University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
- Implantable Microvalve Device - Product Status
- Implantable Microvalve Device - Product Description
- University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
- Closed Glucose-Sensing Insulin-Delivery System - Product Status
- Closed Glucose-Sensing Insulin-Delivery System - Product Description
- WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Closed Loop Insulin Delivery Solution - Product Status
- Closed Loop Insulin Delivery Solution - Product Description
- XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- Bi-Hormonal Artificial Pancreas - Product Status
- Bi-Hormonal Artificial Pancreas - Product Description
- Yale University Pipeline Products & Ongoing Clinical Trials Overview
- Automated Insulin Delivery System - Product Status
- Automated Insulin Delivery System - Product Description
- Glossary
List of Figures
- Artificial Pancreas - Pipeline Products by Stage of Development
- Artificial Pancreas - Pipeline Products by Territory
- Artificial Pancreas - Pipeline Products by Regulatory Path
- Artificial Pancreas - Pipeline Products by Estimated Approval Date
- Artificial Pancreas - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Admetsys Corp
- Advanced Biosensors-Ohio LLC
- Beta Bionics Inc
- Beta-O2 Technologies Ltd
- Bigfoot Biomedical Inc
- BioTex Inc
- Cerco Medical LLC
- Converge Biotech, Inc.
- Covalor Medical, LLC
- De Montfort University
- Debiotech SA
- Defymed SAS
- Diabeloop SA
- EOFlow Co Ltd
- Giner Inc
- Harvard John A Paulson School of Engineering and Applied Sciences
- Healios Inc
- Humacyte Inc
- Ideal Medical Technologies Inc
- Imperial College London
- Inreda Diabetic BV
- Insulet Corp
- Joslin Diabetes Center
- Kencak LLC
- McGill University
- Medtronic Diabetes
- Medtronic Inc
- Miromatrix Medical Inc
- Pacific Diabetes Technologies, Inc.
- Pancreum, LLC
- PharmaCyte Biotech Inc
- Polytechnic University of Valencia
- Rensselaer Polytechnic Institute
- Senseonics Holdings Inc
- Stanford University
- TecMed Inc
- The Alfred Mann Foundation
- TypeZero Technologies LLC
- U-Needle BV
- Universidad Autonoma de Madrid
- University of California San Francisco
- University of California Santa Barbara
- University of Cambridge
- University of Florida
- University of Minnesota
- University of Newcastle
- WaveForm Technologies Inc
- XERIS Pharmaceuticals Inc
- Yale University
